Drug
Trichostatin A
Trichostatin A: highest development phase Phase 2, developed by Vanda Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vanda Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Trichostatin A NCT07065773 | Phase 2 | Onychomycosis of Toenail |
| Trichostatin A NCT03838926 | Phase 1 | Relapsed or Refractory Hematologic Malignancies |
Latest
No recent events.
Follow Trichostatin A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.